Concepedia

Lukas Pekar

LP

Statistics

Publications

14

Citations

363

H-Index

14

Active since

2020

Affiliations

Merck KGaA, Darmstadt (Germany)(Current)

Technische Universität Darmstadt

University Hospital Schleswig-Holstein

University of Lübeck

Christian-Albrechts-Universität zu Kiel

Lukas Pekar is an author at Merck KGaA, Darmstadt (Germany) specializing in immunology, antibody engineering, and bispecific antibodies.

ORCID

Publications per year

2020–2025

14

Publications

14

Affinity Maturation of B7-H6 Translates into Enhanced NK Cell–Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 Engagement

Lukas Pekar, Katja Klausz, Michael Busch et al. · The Journal of Immunology · 2020 · 48 citations · Full text

, , +17

Biophysical and biochemical characterization of a VHH-based IgG-like bi- and trispecific antibody platform

Lukas Pekar, Michael Busch, Bernhard Valldorf et al. · mAbs · 2020 · 34 citations · Full text

, , +17

Beyond bispecificity: Controlled Fab arm exchange for the generation of antibodies with multiple specificities

Desislava Yanakieva, Lukas Pekar, Andreas Evers et al. · mAbs · 2022 · 34 citations · Full text

, , +17

Multifunctional NK Cell–Engaging Antibodies Targeting EGFR and NKp30 Elicit Efficient Tumor Cell Killing and Proinflammatory Cytokine Release

Katja Klausz, Lukas Pekar, Ammelie Svea Boje et al. · The Journal of Immunology · 2022 · 32 citations · Full text

, , +17

A One-Step Process for the Construction of Phage Display scFv and VHH Libraries

Carolin Sellmann, Lukas Pekar, Christina Bauer et al. · Molecular Biotechnology · 2020 · 28 citations

, , +9

1–5 of 14